{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Age-related macular degeneration", "Ceramide", "Ceramide-1-phosphate", "Photoreceptor", "Retinal pigment epithelium", "Sphingosine", "Sphingosine-1-phosphate"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34560541", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.1016/j.biopha.2021.112197", "S0753-3322(21)00981-1"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "143", "PubDate": {"Year": "2021", "Month": "Nov"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "Updates on sphingolipids: Spotlight on retinopathy.", "Pagination": {"StartPage": "112197", "MedlinePgn": "112197"}, "Abstract": {"AbstractText": ["The sphingolipids ceramide (Cer), ceramide-1-phosphate (C1P), sphingosine (Sph), and sphingosine-1-phosphate (S1P)) are key signaling molecules that regulate many patho-biological processes. During the last decade, they have gained increasing attention since they may participate in important and numerous retinal processes, such as neuronal survival and death, proliferation and migration of neuronal and vascular cells, inflammation, and neovascularization. Cer for instance has emerged as a key mediator of inflammation and death of neuronal and retinal pigment epithelium cells in experimental models of retinopathies such as glaucoma, age-related macular degeneration (AMD), and retinitis pigmentosa. S1P may have opposite biological actions, preventing photoreceptor and ganglion cell degeneration but also promoting inflammation, fibrosis, and neovascularization in AMD, glaucoma, and pro-fibrotic disorders. Alterations in Cer, S1P, and ceramide 1- phosphate may also contribute to uveitis. Furthermore, use of inhibitors that either prevent Cer increase or modulate S1P signaling, such as Myriocin, desipramine, and Fingolimod (FTY720), have been shown to preserve neuronal viability and retinal function. Collectively, the expanding role for these sphingolipids in the modulation of vital processes in retina cell types and in their dysregulation in retinal degenerations makes them attractive therapeutic targets."], "CopyrightInformation": "Copyright \u00a9 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Royal Preston Hospital, United Kingdom. Electronic address: SHIWANIH@tcd.ie."}], "LastName": "Shiwani", "ForeName": "Haaris A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, University College Dublin, Ireland."}], "LastName": "Elfaki", "ForeName": "Mohammed Y", "Initials": "MY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Children's Health Ireland at Crumlin, Dublin, Ireland."}], "LastName": "Memon", "ForeName": "Danyal", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Acute Medicine, Ulster Hospital, Belfast, United Kingdom."}], "LastName": "Ali", "ForeName": "Suhayb", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Royal Liverpool University Hospital, Liverpool, United Kingdom."}], "LastName": "Aziz", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut du Savoir Montfort (ISM), H\u00f4pital Montfort, University of Ottawa, Ottawa, ON, Canada; Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon. Electronic address: egomemmanuel@gmail.com."}], "LastName": "Egom", "ForeName": "Emmanuel E", "Initials": "EE"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ceramides"}, {"RegistryNumber": "0", "NameOfSubstance": "Lysophospholipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Sphingolipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Sphingosine 1 Phosphate Receptor Modulators"}, {"RegistryNumber": "0", "NameOfSubstance": "Sphingosine-1-Phosphate Receptors"}, {"RegistryNumber": "0", "NameOfSubstance": "ceramide 1-phosphate"}, {"RegistryNumber": "26993-30-6", "NameOfSubstance": "sphingosine 1-phosphate"}, {"RegistryNumber": "G926EC510T", "NameOfSubstance": "Fingolimod Hydrochloride"}, {"RegistryNumber": "NGZ37HRE42", "NameOfSubstance": "Sphingosine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ceramides"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Fingolimod Hydrochloride"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lysophospholipids"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": ["metabolism"], "DescriptorName": "Photoreceptor Cells, Vertebrate"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Retina"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Retinal Diseases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Retinal Ganglion Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "Retinal Pigment Epithelium"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sphingolipids"}, {"QualifierName": ["analogs & derivatives", "metabolism"], "DescriptorName": "Sphingosine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Sphingosine 1 Phosphate Receptor Modulators"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Sphingosine-1-Phosphate Receptors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "7", "Day": "13"}, {"Year": "2021", "Month": "9", "Day": "8"}, {"Year": "2021", "Month": "9", "Day": "13"}, {"Year": "2021", "Month": "9", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "24", "Hour": "20", "Minute": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34560541", "10.1016/j.biopha.2021.112197", "S0753-3322(21)00981-1"]}}], "PubmedBookArticle": []}